Oral semaglutide is currently available under the brand name Rybelsus for the treatment of type 2 diabetes, and is only prescribed for weight loss off-label
[PubMed] Habegger KM, Heppner KM, Geary N, et al
A 2025 Stanford Medicine study identifying a naturally occurring peptide that suppressed appetite and reduced body weight without the nausea and muscle loss associated with semaglutide confirmed what many clinicians had already observed: the GLP-1 mechanism is powerful, but it carries side effects tied directly to how it works
Some studies suggest that unsaturated fats may promote greater GLP-1 secretion than saturated fats, though more research is needed
Contact us now to protect your rights and pursue the compensation you deserve
Clinical strategies emphasize resistance training and nutrition to preserve up to 97% of lean mass, positioning muscle toning devices like Pure Impact as essential interventions for both pre- and post-therapy